Certified by Founder Lodge
RH Capital
United States - San Francisco, California
INVESTOR
1 Disclosed Funding Rounds $5,000,000
12 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
RH Capital, a Rhia Ventures fund, invests in early-stage high-impact companies that are driving innovation, access, and equity across the reproductive and maternal health landscape. As a wome
| Company | Date | Round | Raised |
|---|---|---|---|
 AOA Dx |
October, 13 ,2023 | Unknown | $17,000,000 |
 Eli Health |
April, 06 ,2023 | Unknown | $5,000,000 |
 Mae |
May, 08 ,2024 | Seed | |
 Evvy |
September, 28 ,2023 | Series A | $14,000,000 |
 Raydiant Oximetry, Inc. |
June, 05 ,2024 | Series A | $7,500,000 |
| AOA Dx |
October, 13 ,2023 | Unknown | $17,000,000 |
 Novocuff, Inc. |
July, 18 ,2024 | Series A | $26,000,000 |
| Mae |
May, 08 ,2024 | Seed | |
| Raydiant Oximetry, Inc. |
June, 05 ,2024 | Series A | $7,500,000 |
| Novocuff, Inc. |
July, 18 ,2024 | Series A | $26,000,000 |
 Seven Starling |
August, 08 ,2024 | Series A | $10,900,000 |
 Twentyeight Health |
January, 08 ,2025 | Series A | $10,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
